NAYA Biosciences Inc (NAYA) - Yalpi foyda normasi

NAYA (NAYA Bio) - kompaniyaning tovar belgisi

NAYA Biosciences zamonaviy bispesifik antitanachalarni ishlab chiqadi va sog'liqni saqlash gigantlari tomonidan sotib olinishining oldini olish uchun o'z innovatsiyalarini FLEX-NK patentlari bilan himoya qiladi. Konsolidatsiyalashgan yalpi foyda xarajatlar samaradorligini ko'rsatadi, 34.20 ko'rsatkichi esa daromadlilik parametrining holatini belgilaydi. Operatsiyalar gumanitar immunitetni saqlagan holda, xavfsiz boshpana hisoblangan AQSh yurisdiksiyalarida amalga oshirilmoqda. Hozirgi vaqtda NAYA Biosciences barqaror operatsion daromadlar yetishmasligi sababli tashqi moliyalashtirish va grantlarga tayanmoqda.

NAYA: NAYA Biosciences Inc. Yalpi marja 04.07.2022 - 28.04.2025

nayabiosciences.com (NAYA) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi ko'rsatkichlari:
Fundamental baholash:NAYA, NAYA Biosciences Inc.
NAYA Biosciences brend mahsuloti

NAYA Biosciences kompaniyasining saraton terapiyasi uchun innovatsion antitelalarni ishlab chiqishi maqsadli dori vositalarini yaratishning xarajatlar tuzilmasini belgilaydi. Valo martba (Gross margin) bevosita ishlab chiqarish xarajatlaridan keyin qolgan daromad qismini o'lchaydi va texnologik platformadan foydalanish samaradorligini aks ettiradi. Bazaviy valo martbaning keskin o'zgarishlari operatsion rentabellikdagi siljishlardan darak beradi, bu esa investorlarga kapitalning muzlab qolish xavfini yoki o'sish potentsialini o'z vaqtida aniqlash imkonini beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|AURA (Aura Biosciences Inc) - Yalpi marja|Yalpi foyda marjasi candeltx.com CADL|Yalpi marja ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Yalpi foyda normasi|Yalpi rentabellik Actuate Therapeutics, Inc. ACTU|citiusonc.com - Yalpi rentabellik|TuHURA Biosciences Inc. - Yalpi marja|TARA - Yalpi marja|FATE (Fate Therapeutics) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Aadi Bioscience, Inc.|Yalpi foyda bo'yicha rentabellik TCRX|Yalpi rentabellik CSBR|Yalpi marja XBIT|Yalpi foyda bo'yicha sotuv rentabelligi CEL-SCI Corp.|Yalpi rentabellik ostherapies.com OSTX|RADX: Sotuvning yalpi rentabelligi|ARTV: Yalpi foyda bo'yicha rentabellik|ANL (Adlai Nortye) - Sotuvning yalpi rentabelligi|Veru (VERU) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Tempest Therapeutics Inc|Yalpi rentabellik Xilio Therapeutics|Sotuvning yalpi rentabelligi RENB (Renovaro Inc.)|Yalpi rentabellik Mural Oncology PLC (MURA)|Yalpi marja Kairos Pharma (KAPA)|Yalpi rentabellik onkuretherapeutics.com OKUR|GDTC: Sotuvning yalpi rentabelligi|CRIS: Yalpi foyda bo'yicha rentabellik|apollomicsinc.com (APLM) - Yalpi foyda bo'yicha rentabellik|THAR: Yalpi marja|Yalpi foyda bo'yicha rentabellik Advanced Biomed Inc.|Yalpi foyda bo'yicha rentabellik GNPX|Sotuvning yalpi rentabelligi CLDI (Calidi Biotherapeutics)|Yalpi marja SBFM|Xenetic Biosciences, Inc. - Sotuvning yalpi rentabelligi|Yalpi rentabellik Salarius Pharmaceuticals SLRX|Yalpi marja purple-biotech.com PPBT|AONC - Yalpi rentabellik|BGNE: Yalpi rentabellik|CKPT: Yalpi marja|Elevation Oncology - Yalpi foyda normasi|ICAD (iCAD) - Yalpi marja|IKNA: Yalpi foyda normasi|Yalpi rentabellik Notable Labs (NTBL)|VIRX (Viracta Therapeutics, Inc.) - Yalpi foyda normasi|Yalpi rentabellik MorphoSys Corporation MOR|AAPGV - Yalpi foyda bo'yicha rentabellik